Fri 23'rd Feb 2018
Cytori Therapeutics Inc Stock Analysis
Technical stock analysis for Fri 23'rd Feb 2018
|Shorts||0.80% ( 2018-01-31 )|
Cytori Therapeutics Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.27% during the next 3 months and, with 90% probability hold a price between $0.37 and $0.65 at the end of this period.
Some negative signals were issued as well, and these may have some influence on the near short-term development. Cytori Therapeutics Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.37. On a fall, the stock will find some support from the short-term average at $0.34. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Thursday February 22, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 44 and the stock is currently not being overbought or oversold
Support & Resistance
Cytori Therapeutics Inc finds support from accumulated volume at $0.34. On the upside the stock meets some resistance from accumulated volume at $0.38, $0.40 and $0.42.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 6.96%. For the last week the stock has had a daily average volatility of 8.31%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Cytori Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
Trade CYTX CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder